Larten en es it fr

Larten Brand names, Larten Analogs

Larten Brand Names Mixture

  • No information avaliable

Larten Chemical_Formula


Larten RX_link

No information avaliable

Larten fda sheet

Larten msds (material safety sheet)

Larten Synthesis Reference

No information avaliable

Larten Molecular Weight

309.469 g/mol

Larten Melting Point

< 25 oC

Larten H2O Solubility

Soluble as HCl salt

Larten State


Larten LogP


Larten Dosage Forms

Tablets (oral, 1 mg)

Larten Indication

Used for the symptomatic treatment of parkinsonism.

Larten Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Larten Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Larten side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Larten Patient Information

Larten Organisms Affected

Humans and other mammals